Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated gh secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers

Journal of Clinical Endocrinology and Metabolism

Volumn 72, Issue 3, 1991, Pages 675-681

  Miell, John P ^a,b   Corder, Roger ^a   Pralong, François P ^a   Gaillard, Rolf C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DEXAMETHASONE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GONADORELIN; QUINAGOLIDE; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AMINOQUINOLINES; ARGININE; BLOOD GLUCOSE; DEXAMETHASONE; DOPAMINE; DOPAMINE AGENTS; GROWTH HORMONE; HUMAN; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; MALE; PROLACTIN; SOMATOTROPIN-RELEASING HORMONE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025857211     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-72-3-675     Document Type: Article

References (43)

1. Preece MA. The effect of administered corticosteroids on the growth of children. Postgrad Med J. 1976;52:625-30.
2. Blodgett FM, Burgin L, Iezzoni D, Gribetz D, Talbot ND. Effects of prolonged corticosterone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med. 1956;254:636-41.
3. Evans HM, Simpson ME, Li CH. Inhibiting effects of adrenocorticotropic hormone on the growth of male rats. Endocrinology. 1943;33:237-8.
4. Hodges JR, Vernikos J. A comparison of the pituitary inhibitory effects of prednisone, prednisolone and hydrocortisone. Br J Pharmacol Chemother. 1958;13:98-102.
5. Takeda R, Nakabayashi H, Usukura N, Hosojima H, Kawato M, Ueda M. Suppressive effects of glucocorticoids on arginine induced growth hormone release in normal subjects. Steroids Lipids Res. 1974;5:193-99.
6. Nakagawa K, Mashimo K. Suppression of exercise induced growth hormone release with dexamethasone. Horm Metab Res. 1973;5:225-6.
7. Nakagawa K, Horiuchi Y, Mashimo K. Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone. J Clin Endocrinol Metab. 1969;29:35-40.
8. Frantz AG, Rabkin MT. Human growth hormone: clinical measurement, response to hypoglycaemia and suppression by corticosteroids. N Engl J Med. 1969;271:1375-81.
9. Hartog M, Gaafar MA, Fraser R. Effect of corticosteroids on serum growth hormone. Lancet. 1964;2:376-8.
10. Hotta M, Shibasaki T, Masuda A, et al. Effect of human growth hormone releasing hormone on GH secretion in Cushing’s syndrome and non-endocrine disease patients treated with glucocorticoids. Life Sci. 1988;42:979-84.
11. Morris HG, Jorgensen JR, Jenkins SA. Plasma growth hormone concentration in glucocorticoid-treated children. J Clin Invest. 1968;47:427-35.
12. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva FF. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology. 1990;51:51-8.
13. Casanueva FF, Burguera B, Tome MA, et al. Depending on the time of administration, dexamethasone potentiates or blocks growth hormone releasing hormone-induced growth hormone release in man. Neuroendocrinology. 1988;7:46-9.
14. Bancroft FC, Levine L, Tashijian AH. Control of growth hormone production by a clonal strain of rat pituitary cells: stimulation by hydrocortisone. J Cell Biol. 1969;43:432-41.
15. Kohler PO, Bridson WE, Rayford PL. Cortisol stimulation of growth hormone production by monkey adenohypophysis in tissue culture. Biochem Biophys Res Commun. 1969;33:834-40.
16. Ooesterom R, Verleun T, Lamberts SWJ. Human growth hormone secreting pituitary adenoma cells in culture: effects of dexamethasone and growth hormone releasing factor. J Endocrinol. 1984;100:353-60.
17. Vale W, Vaughn J, Yamamoto G, Speiss J, Rivier J. Effects of synthetic human pancreatic (tumour) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology. 1983;112:1553-5.
18. Gertz BJ, Gardiner DG, Baxter JD. Glucocorticoid control of rat GH gene expression: effect on cytoplasmic messenger RNA production and degradation. Mol Endocrinol. 1987;1:933-41.
19. Nyborg JK, Nguyen AP, Spindler SR. Relationship between thyroid and glucocorticoid hormone receptor occupancy, growth hormone gene transcription and mRNA accumulation. J Biol Chem. 1984;259:12377-81.
20. Martial JA, Seeburg PH, Guenzi D, Goodman HM, Baxter JD. Regulation of growth hormone gene expression: synergistic effects of thyroid and glucocorticoid hormones. Proc Natl Acad Sci USA. 1977;74:4293-5.
21. Siefert H, Perrin M, Rivier J, Vale W. Growth hormone-releasing factor binding sites in rat anterior pituitary homogenates: modulation by glucocorticoids. Endocrinology. 1985;117:424-6.
22. Giustina A, Romanelli G, Candrina R, Giustina G. Growth hormone deficiency in patients with idiopathic adrenocorticotrophin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab. 1989;68:120-4.
23. Morris HG, Jorgensen JR, Elrick H, Goldsmith RE, Subryan VL. Metabolic effects of human growth hormone in corticosteroid treated children. J Clin Invest. 1968;47:436-51.
24. Ward DJ, Hartog M, Ansell BM. Corticosteroid induced dwarfism in Still’s disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in 2 cases. Ann Rheum Dis. 1966;26:416-21.
25. Unterman TG, Phillips LS. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab. 1985;61:618-26.
26. Miell JP, Pralong FP, Corder R, Gaillard RC. Stimulation of GH release in man by the potent D2-dopamine agonist CV 205-502: comparison of responses to intravenous and oral administration. J Clin Endocrinol Metab. (In Press).
27. Le Clerq R, Copinsh G, Franckson JRM. Le dosage par compétition du cortisol plasmatique: modification de la méthode de Murphy. Rev Etudes Clin Biol. 1969;14:815-9.
28. Nakagawa K, Akikawa K, Matsubara M, Kubo M. Effect of dexaméthasone on growth hormone response to growth hormone releasing hormone in acromegaly. J Clin Endocrinol Metab. 1985;60:306-10.
29. Wehrenberg WB, Baird A, Ling N. Potent interaction between glucocorticoids and growth hormone releasing factor in vivo. Science. 1983;221:556-8.
30. Janssen J-O, Ekberg S, Isaakson OGP, et al. Influence of gonadal steroids on age and sex related secretory patterns of growth hormone in the rat. Endocrinology. 1984;114:1287-94.
31. Nakagawa K, Ishizuka T, Obara T, et al. Dichotomic action of glucocorticoids on growth hormone secretion. Acta Endocrinol (Copenh). 1987;116:165-71.
32. Wehrenberg WB, Baird A, Klepper R, Mormede P, Ling N. Interactions between growth hormone-releasing hormone and glucocorticoids in male rats. Regul Peptides. 1989;25:147-55.
33. Corder R, Saudan P, Mazlan M, McLean C, Gaillard RC. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats. Neuroendocrinology. 1990;51:85-92.
34. Gacs G, Kun E, Czirbesz Z. Growth hormone secretion in children during corticosteroid treatment. Responses to arginine. Horm Metab Res. 1973;5:106-8.
35. Alba-Roth J, Muller A, Schopohl J, von Werder K. Arginine stimulates growth hormone secretion by suppression of endogenous somatostatin secretion. J Clin Endocrinol Metab. 1988;67:1186-9.
36. Olendorf WH. Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am J Physiol. 1971;221:1629-39.
37. Kuchel O, Buu R, Serri O. Dopamine negatively modulates its own blood pressure increasing action. Can J Cardiol. 1987;3:18-22.
38. Vance ML, Kaiser DL, Frohmann LA, Rivier J, Vale WW, Thorner MO. Role of dopamine in the regulation of GH secretion: dopamine and bromocriptine augment GHRH stimulated GH secretion in normal man. J Clin Endocrinol Metab. 1987;64:1136-41.
39. Delitala G, Palermo M, Ross R, Coy D, Besser GM, Grossman A. Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology. 1987;45:243-7.
40. Copeland KC, Underwood L, Van Wyk J. Induction of immuno-reactive somatomedin C in human serum by GH: dose response relationships and effects on chromatographic profiles. J Clin Endocrinol Metab. 1980;50:690-7.
41. Vance ML, Borges JLC, Kaiser DL, et al. Human pancreatic growth hormone-releasing factor: dose response relationships in normal men. J Clin Endocrinol Metab. 1984;58:838-44.
42. Gourmelen M, Girard F, Binoux M. Serum somatomedin/insulin like growth factor (IGF) and IGF carrier levels in patients with Cushing’s syndrome or receiving glucocorticoid therapy. J Clin Endocrinol Metab. 1987;54:885-92.
43. Thoren M, Hall K, Rahn T. Somatomedin A levels in patients with Cushing’s disease. Acta Endocrinol (Copenh). 1981;97:12-7.